1. A design strategy for D–A conjugated polymers for NIR-II fluorescence imaging. Issue 32 (1st August 2021) Authors: Su, Yingbin; Miao, Yawei; Zhu, Yaowei; Zou, Wentao; Yu, Bing; Shen, Youqing; Cong, Hailin Journal: Polymer chemistry Issue: Volume 12:Issue 32(2021) Page Start: 4707 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A rational design of polymers through donor modulation to weaken the aggregation-caused quenching effect for NIR-II fluorescence imaging. Issue 10 (14th February 2023) Authors: Zhu, Yaowei; Li, Lili; Sun, Bin; Zhang, Min; Zhang, Chunmei; Xiao, Chunsheng; Chen, Li Journal: Journal of materials chemistry Issue: Volume 11:Issue 10(2023) Page Start: 2129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Conjugated‐Polymer‐Based Nanoparticles with Efficient NIR‐II Fluorescent, Photoacoustic and Photothermal Performance. (1st October 2019) Authors: Miao, Yawei; Gu, Chuantao; Yu, Bing; Zhu, Yaowei; Zou, Wentao; Shen, Youqing; Cong, Hailin Journal: Chembiochem Issue: Volume 20:Number 21(2019) Page Start: 2793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. D–A polymers for fluorescence/photoacoustic imaging and characterization of their photothermal properties. Issue 42 (7th October 2019) Authors: Zhu, Yaowei; Gu, Chuantao; Miao, Yawei; Yu, Bing; Shen, Youqing; Cong, Hailin Journal: Journal of materials chemistry Issue: Volume 7:Issue 42(2019) Page Start: 6576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Evaluating Potential Disease‐Mediated Protein‐Drug Interactions in Patients With Moderate‐to‐Severe Plaque Psoriasis Receiving Subcutaneous Guselkumab. Issue 6 (28th May 2020) Authors: Zhu, Yaowei; Xu, Yan; Zhuang, Yanli; Piantone, Alexa; Shu, Cathye; Chen, Dion; Zhou, Honghui; Xu, Zhenhua; Sharma, Amarnath Journal: Clinical and translational science Issue: Volume 13:Issue 6(2020) Page Start: 1217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Extrapolating Pharmacodynamic Effects From Adults to Pediatrics: A Case Study of Ustekinumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis. Issue 1 (10th October 2020) Authors: Zhou, Wangda; Hu, Chuanpu; Zhu, Yaowei; Randazzo, Bruce; Song, Michael; Sharma, Amarnath; Xu, Zhenhua; Zhou, Honghui Journal: Clinical pharmacology & therapeutics Issue: Volume 109:Issue 1(2021) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo‐Controlled Phase III Trial. Issue 12 (December 2015) Authors: Kavanaugh, Arthur; Puig, Lluís; Gottlieb, Alice B.; Ritchlin, Christopher; Li, Shu; Wang, Yuhua; Mendelsohn, Alan M.; Song, Michael; Zhu, Yaowei; Rahman, Proton; McInnes, Iain B. Journal: Arthritis care & research Issue: Volume 67:Issue 12(2015:Dec.) Page Start: 1739 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Population Pharmacokinetic Modeling of Guselkumab, a Human IgG1λ Monoclonal Antibody Targeting IL‐23, in Patients with Moderate to Severe Plaque Psoriasis. (17th January 2018) Authors: Yao, Zhenling; Hu, Chuanpu; Zhu, Yaowei; Xu, Zhenhua; Randazzo, Bruce; Wasfi, Yasmine; Chen, Yang; Sharma, Amarnath; Zhou, Honghui Journal: Journal of clinical pharmacology Issue: Volume 58:Number 5(2018) Page Start: 613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Recent Progress in Fluorescence Imaging of the Near‐Infrared II Window. (9th November 2018) Authors: Miao, Yawei; Gu, Chuantao; Zhu, Yaowei; Yu, Bing; Shen, Youqing; Cong, Hailin Journal: Chembiochem Issue: Volume 19:Number 24(2018) Page Start: 2522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Serum Autoantibody Lowering by the Anti-FcRn Monoclonal Antibody, Nipocalimab, Correlates With Clinical Improvement in Generalized Myasthenia Gravis Patients. (5th December 2022) Authors: Ramchandren, Sindhu; Guptill, Jeff; Antozzi, Carlo; Bril, Vera; Gamez, Josep; Meuth, Sven; Nowak, Richard; Quan, Dianna; Sevilla Mantecon, Maria Teresa; Ling, Leona; Zhu, Yaowei; Karcher, Keith; Sun, Hong Journal: Neurology Issue: Volume 99:Number 23(2022)Supplement 2 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗